Home
/
Teladoc Health, Inc.
/
Financials
/
Quarterly
Teladoc Health, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Teladoc Health, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2023
Mar 31, 2023
$629.24M
May 2, 2023
Q1
2023
Mar 31, 2022
$565.35M
May 2, 2023
Q3
2018
Sep 30, 2018
$110.96M
Nov 1, 2018
Q2
2018
Jun 30, 2018
$94.56M
Aug 1, 2018
Q1
2018
Mar 31, 2018
$89.64M
May 1, 2018
Q3
2018
Sep 30, 2017
$68.65M
Nov 1, 2018
Q2
2018
Jun 30, 2017
$44.59M
Aug 1, 2018
Q1
2018
Mar 31, 2017
$42.90M
May 1, 2018
Q3
2017
Sep 30, 2016
$32.38M
Nov 1, 2017
Q2
2017
Jun 30, 2016
$26.49M
Aug 2, 2017
Q1
2017
Mar 31, 2016
$26.89M
May 8, 2017
Q3
2016
Sep 30, 2015
$19.97M
Oct 27, 2016
Q2
2016
Jun 30, 2015
$18.28M
Aug 3, 2016
Q1
2016
Mar 31, 2015
$16.49M
May 10, 2016
Q3
2015
Sep 30, 2014
$10.91M
Nov 2, 2015
Q2
2015
Jun 30, 2014
$10.29M
Aug 12, 2015
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$626.44M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$631.90M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$629.37M
May 1, 2025
Q3
2025
Sep 30, 2024
$640.51M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$642.44M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$646.13M
May 1, 2025
Q3
2024
Sep 30, 2023
$660.24M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$652.41M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$629.24M
Apr 26, 2024
Q3
2023
Sep 30, 2022
$611.40M
Oct 27, 2023
Q2
2023
Jun 30, 2022
$592.38M
Jul 28, 2023
Q1
2023
Mar 31, 2022
$565.35M
May 2, 2023
Q3
2022
Sep 30, 2021
$521.66M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$503.14M
Aug 3, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($49.51M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($32.66M)
Jul 30, 2025
Q1
2025
Mar 31, 2025
($93.01M)
May 1, 2025
Q3
2025
Sep 30, 2024
($33.28M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($837.67M)
Jul 30, 2025
Q1
2025
Mar 31, 2024
($81.89M)
May 1, 2025
Q3
2024
Sep 30, 2023
($57.07M)
Oct 31, 2024
Q2
2024
Jun 30, 2023
($65.18M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($69.23M)
Apr 26, 2024
Q3
2023
Sep 30, 2022
($73.48M)
Oct 27, 2023
Q2
2023
Jun 30, 2022
($3.10B)
Jul 28, 2023
Q1
2023
Mar 31, 2022
($6.67B)
May 2, 2023
Q3
2022
Sep 30, 2021
($84.34M)
Nov 2, 2022
Q2
2022
Jun 30, 2021
($133.82M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($199.65M)
May 2, 2022
Q2
2021
Mar 31, 2021
($199.65M)
Aug 2, 2021
Q3
2021
Sep 30, 2020
($35.88M)
Nov 1, 2021
Q2
2021
Jun 30, 2020
($25.68M)
Aug 2, 2021
Q3
2020
Jun 30, 2020
($25.68M)
Nov 6, 2020
Q3
2020
Mar 31, 2020
($29.60M)
Nov 6, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($51.96M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($54.39M)
Jul 30, 2025
Q1
2025
Mar 31, 2025
($120.61M)
May 1, 2025
Q3
2025
Sep 30, 2024
($44.40M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($841.15M)
Jul 30, 2025
Q1
2025
Mar 31, 2024
($87.12M)
May 1, 2025
Q3
2024
Sep 30, 2023
($64.73M)
Oct 31, 2024
Q2
2024
Jun 30, 2023
($71.65M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($77.10M)
Apr 26, 2024
Q3
2023
Sep 30, 2022
($71.73M)
Oct 27, 2023
Q2
2023
Jun 30, 2022
($3.10B)
Jul 28, 2023
Q1
2023
Mar 31, 2022
($6.67B)
May 2, 2023
Q3
2022
Sep 30, 2021
($60.58M)
Nov 2, 2022
Q2
2022
Jun 30, 2021
($78.95M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($84.68M)
May 2, 2022
Q3
2021
Sep 30, 2020
($19.73M)
Nov 1, 2021
Q2
2021
Jun 30, 2020
($7.18M)
Aug 2, 2021
Q1
2021
Mar 31, 2020
($21.01M)
May 3, 2021
Q3
2020
Sep 30, 2019
($19.94M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($22.02M)
Jul 29, 2020